Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Anaesth. pain intensive care. 2022; 26(1): 44-52


Effect of Lidocaine Intravenous Infusion Compared to Dexmedetomidine Intravenous Infusion on Proinflammatory Cytokines and Stress Response in Pelviabdominal Cancer Surgeries: A Randomized Clinical Trial

Mohamed Mahmoud Hassan, Emad Gerges Saleh, Norma Osama Abdalla, Noha Hassan Radwan, Ekramy Mansour Abdelghfar.




Abstract

Background: Stress response to cancer surgeries results in impaired balance between pro-inflammatory and anti-inflammatory cytokines besides activating an inflammatory cascade. Therefore, we investigated the effect of intravenous infusion (IVI) of dexmedetomidine and lidocaine on proinflammatory cytokines and some stress reaction.
Methods: A randomized study was performed in National Cancer Institute. 54 patients scheduled for pelviabdominal cancer surgery under general anaesthesia were randomly allocated to either of the study groups, Lidocaine group: received 1.5 mg/kg loading dose followed by 1.5 mg/kg/hour IVI; Dexmedetomidine group: received a loading dose of 1µg/kg followed by IVI of 0.5µg/kg/hour; or Saline group: received 50 ml of normal saline followed by IVI intraoperatively at a rate of 10 ml/hour till the end of surgery. The primary outcome is reaching postoperative level of IL-6 after 24 hours.
Results: Immediate and 24 hours postoperative IL-6 and TNFα were significantly lower in both dexmedetomidine and lidocaine groups compared to control group (P

Key words: Lidocaine; dexmedetomidine; interleukins; tumour necrosis factor- α; stress response; pelviabdominal cancer surgeries.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.